These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18551103)

  • 41. Target organ damage in newly detected hypertensive patients.
    Prakash D
    J Family Med Prim Care; 2019 Jun; 8(6):2042-2046. PubMed ID: 31334177
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Dahlof B;
    Circulation; 2003 Aug; 108(6):684-90. PubMed ID: 12885747
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study].
    González-Juanatey JR; Cea-Calvo L; Bertomeu V; Aznar J;
    Rev Esp Cardiol; 2007 Feb; 60(2):148-56. PubMed ID: 17338880
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Depression, cardiometabolic function and left ventricular hypertrophy in African men and women: the SABPA study.
    Mashele N; Malan L; van Rooyen JM; Harvey BH; Potgieter JC; Hamer M
    Clin Exp Hypertens; 2013; 35(3):213-9. PubMed ID: 22954159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combining ECG Criteria for Left Ventricular Hypertrophy Improves Risk Prediction in Patients With Hypertension.
    Okin PM; Hille DA; Kjeldsen SE; Devereux RB
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29151037
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypertension and associated factors in older adults in South Africa.
    Peltzer K; Phaswana-Mafuya N
    Cardiovasc J Afr; 2013 Apr; 24(3):67-71. PubMed ID: 23736129
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of new hypertension guidelines on target organ damage screening in a Shanghai community-dwelling population.
    Wang Q; Chao H; Zheng S; Tan I; Butlin M; Avolio A; Zuo J
    J Clin Hypertens (Greenwich); 2019 Oct; 21(10):1450-1455. PubMed ID: 31532579
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension.
    Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Gattobigio R; Zampi I; Porcellati C
    J Am Coll Cardiol; 1998 Feb; 31(2):383-90. PubMed ID: 9462583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Burden of cardiometabolic risk factors and preclinical target organ damage among adults in Freetown, Sierra Leone: a community-based health-screening survey.
    Russell JBW; Koroma TR; Sesay S; Samura SK; Lakoh S; Bockarie A; Abir OT; Kanu JS; Coker J; Jalloh A; Conteh V; Conteh S; Smith M; Mahdi OZ; Lisk DR
    BMJ Open; 2023 May; 13(5):e067643. PubMed ID: 37192807
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Target organ damage among hypertensive adults in rural Nigeria: a cross-sectional study.
    Nelissen HE; Hendriks ME; Wit FW; Bolarinwa OA; Osagbemi GK; Bindraban NR; Lange JM; Akande TM; Schultsz C; Brewster LM
    J Hypertens; 2014 Mar; 32(3):487-94. PubMed ID: 24299916
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence and correlates of left atrial enlargement in essential hypertension: role of ventricular geometry and the metabolic syndrome: the Evaluation of Target Organ Damage in Hypertension study.
    Cuspidi C; Meani S; Fusi V; Valerio C; Catini E; Sala C; Sampieri L; Magrini F; Zanchetti A
    J Hypertens; 2005 Apr; 23(4):875-82. PubMed ID: 15775794
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Race and hypertensive target-organ damage in patients from an university-affiliated outpatient care referral clinic in the city of Salvador.
    Noblat AC; Lopes MB; Lopes AA
    Arq Bras Cardiol; 2004 Feb; 82(2):116-20, 111-5. PubMed ID: 15042247
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determinants and treatment of hypertension in South Africans: the first Demographic and Health Survey.
    Steyn K; Bradshaw D; Norman R; Laubscher R
    S Afr Med J; 2008 May; 98(5):376-80. PubMed ID: 18637309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study.
    Okin PM; Devereux RB; Jern S; Julius S; Kjeldsen SE; Dahlöf B
    Am J Hypertens; 2001 Aug; 14(8 Pt 1):775-82. PubMed ID: 11497193
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.
    Calderón A; Barrios V; Escobar C; Ferrer E; Barrios S; González-Pedel V; Montoro P; Navarro-Cid J
    Clin Exp Hypertens; 2010 May; 32(3):145-53. PubMed ID: 20504121
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of left ventricular hypertrophy in Finnish primary health care hypertensive patients.
    Kumpusalo E; Lappi J; Miettinen H; Takala J
    J Hum Hypertens; 2001 Apr; 15(4):255-8. PubMed ID: 11319673
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Creatinine clearance and signs of end-organ damage in primary hypertension.
    Leoncini G; Viazzi F; Parodi D; Ratto E; Vettoretti S; Vaccaro V; Ravera M; Tomolillo C; Deferrari G; Pontremoli R
    J Hum Hypertens; 2004 Jul; 18(7):511-6. PubMed ID: 15002001
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence and correlates of hypertension: a cross-sectional study among rural populations in sub-Saharan Africa.
    de Ramirez SS; Enquobahrie DA; Nyadzi G; Mjungu D; Magombo F; Ramirez M; Sachs SE; Willett W
    J Hum Hypertens; 2010 Dec; 24(12):786-95. PubMed ID: 20220771
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Racial differences in sudden cardiac death among hypertensive patients during antihypertensive therapy: the LIFE study.
    Okin PM; Kjeldsen SE; Julius S; Dahlöf B; Devereux RB
    Heart Rhythm; 2012 Apr; 9(4):531-7. PubMed ID: 22079554
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Left ventricular hypertrophy among black hypertensive patients: focusing on the efficacy of angiotensin converting enzyme inhibitors.
    Jaleta GN; Gudina EK; Getinet W
    BMC Res Notes; 2014 Jan; 7():45. PubMed ID: 24444396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.